A Simple, Repeatable Business Model

  • Delivering strong execution & pioneering innovation via a proven operating model – spanning an ecosystem of Instruments, Informatics, Consumables & Service

Life Sciences Leader in Regulated, High-Volume Applications

  • Embedded in Pharma QA/QC, Clinical, & Advanced Diagnostic workflows

  • >70% of Revenue Annually Recurring

  • >20% of Revenue Typically Converted into Free Cash Flow

Industry-Leading Financial Outlook (2025-30E)

  • 7% Revenue Growth CAGR

  • 500bps Adj. EBIT Margin Expansion

  • Mid-Teens% Adj. EPS Growth Annualized

Latest News

Latest Events

Our Portfolio

Featured Investor Presentation